Geneva, May 4 -- International Clinical Trials Registry received information related to the study (KCT0011898) titled 'A randomized study comparing low-dose and standard-dose anticoagulation in patients receiving venoarterial ECMO' on April 23.
Study Type: Interventional Study
Study Design:
Primary Purpose : Treatment, Intervention Model : Parallel, Blinding/Masking : Single, Blinding Target : Subject, Allocation : RCT
Primary Sponsor: Seoul National University Hospital
Condition:
Symptoms, signs and abnormal clinical and laboratory findings, NEC
Intervention:
Drug : All patients will start intravenous infusion of heparin, an anticoagulant, immediately after ECMO initiation.
- Intervention arm (Low-dose anticoagulation arm): low...